2016
DOI: 10.1155/2016/4638683
|View full text |Cite
|
Sign up to set email alerts
|

Confocal Laser Endomicroscopy in Gastrointestinal and Pancreatobiliary Diseases: A Systematic Review and Meta-Analysis

Abstract: Confocal laser endomicroscopy (CLE) is an endoscopic-assisted technique developed to obtain histopathological diagnoses of gastrointestinal and pancreatobiliary diseases in real time. The objective of this systematic review is to analyze the current literature on CLE and to evaluate the applicability and diagnostic yield of CLE in patients with gastrointestinal and pancreatobiliary diseases. A literature search was performed on MEDLINE, EMBASE, Scopus, and Cochrane Oral Health Group Specialized Register, using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
63
0
6

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 91 publications
(69 citation statements)
references
References 130 publications
(154 reference statements)
0
63
0
6
Order By: Relevance
“…A recent meta-analysis43 performed on CLE and gastric diseases, focused on three domains: (1) detection and diagnosis of polyps and neoplastic lesions (three studies, sensitivity 85% (95% CI 78% to 91%, I 2 =52.3%), specificity 99% (95% CI 98% to 99%, I 2 =92.92%), AUC=0.929), (2) gastritis and gastric metaplasia (six studies, sensitivity 94% (95% CI 92% to 96%, I 2 =54.8%), specificity 95% (CI 92% to 97%, I 2 =55.6%), AUC=0.983) and (3) H. pylori -related gastritis (two studies, sensitivity 86% (95% CI 76% to 93%, I 2 =0), specificity 93% (95% CI 87% to 97%, I 2 =2.6%)). The pooled analyses demonstrated CLE yields remarkable sensitivity and specificity, in per patient analysis in all three domains.…”
Section: Confocal Laser Endomicroscopy (Cle)mentioning
confidence: 99%
“…A recent meta-analysis43 performed on CLE and gastric diseases, focused on three domains: (1) detection and diagnosis of polyps and neoplastic lesions (three studies, sensitivity 85% (95% CI 78% to 91%, I 2 =52.3%), specificity 99% (95% CI 98% to 99%, I 2 =92.92%), AUC=0.929), (2) gastritis and gastric metaplasia (six studies, sensitivity 94% (95% CI 92% to 96%, I 2 =54.8%), specificity 95% (CI 92% to 97%, I 2 =55.6%), AUC=0.983) and (3) H. pylori -related gastritis (two studies, sensitivity 86% (95% CI 76% to 93%, I 2 =0), specificity 93% (95% CI 87% to 97%, I 2 =2.6%)). The pooled analyses demonstrated CLE yields remarkable sensitivity and specificity, in per patient analysis in all three domains.…”
Section: Confocal Laser Endomicroscopy (Cle)mentioning
confidence: 99%
“…13,30 Fluorescent light is then reflected from the selected tissue through the aperture, which excludes any light reflected at angles that do not refocus into the lens. [31][32][33][34] In essence, this adjunct to EUS acts as an "optical biopsy" by providing realtime tissue histopathology. 32,35 Intravenous fluorescent agents are used to image the tissue mucosa.…”
Section: Confocal Laser Endomicroscopymentioning
confidence: 99%
“…[33][34][35] Currently, two primary modalities of CLE are available: endoscope-based confocal laser endomicroscopy (eCLE) created by Pentax (Pentax America, Montvale, NJ, USA) and Optiscan (Optiscan, Notting Hill, Australia) which incorporates the confocal scanner into the distal tip of conventional endoscopes and a probe-based confocal laser endomicroscopy (pCLE) which is miniaturized to 250-300 μm, allowing it to be introduced through endoscopic accessory channels (Cellvizio; Mauna Kea Technologies, Paris, France). 13,33,34,35 This is an exciting advancement in EUS, as it can guide treatment decisions for various diseases in real-time while also preventing unnecessary biopsies. eCLE has been used to optimize endoscopic detection of colonic polyps, dysplasia in Barrett esophagus, and neoplasia in inflammatory bowel disease.…”
Section: Confocal Laser Endomicroscopymentioning
confidence: 99%
See 2 more Smart Citations